Register for #ASGCTBreakthroughs24 to learn about the latest advancements in CGT for muscular dystrophy! Join us Nov. 19-20 in Chicago or virtually.
Join ASGCT and the Muscular Dystrophy Association on November 19-20, at The Westin Michigan Avenue Chicago or online, for an unparalleled opportunity to explore the latest advancements in gene and cell therapies for muscular dystrophy.
This 1.5-day event Nov. 19-20 will bring together leading researchers and clinicians from the neuromuscular disease community to explore cutting-edge gene and cell therapies and technologies for muscular dystrophy.
This comprehensive conference features world-renowned speakers and covers critical topics in muscular dystrophy research, including:
Keynote on Genetic Therapies for Muscular Dystrophies: Cloning the Duchenne Gene - An Origin Story - Dr. Louis Kunkel (Children's Hospital Boston)
Keynote on Clinical Aspects of Gene Therapies for Muscular Dystrophies - Challenges and Opportunities - Dr. Carsten Bönnemann (NINDS/NIH)
Non-Viral and Viral Delivery Methods
Monitoring AAV Delivery
Gene Editing Techniques
RNA Targeted Therapies
Panel Discussion on the Future of Genetic Therapies for Muscular Dystrophies
Additional features include oral abstract sessions, a poster reception, and ample networking opportunities.
View the full program Register now!
November 19-20, 2024 | Chicago, IL
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico